Rchr
J-GLOBAL ID:201801011274034033
Update date: Oct. 02, 2024
Katagiri Toyomasa
カタギリ トヨマサ | Katagiri Toyomasa
Affiliation and department:
Homepage URL (1):
http://www.genome.tokushima-u.ac.jp/dgm/
Research field (2):
Pathobiochemistry
, Tumor biology
Research keywords (4):
癌抑制遺伝子
, 分子標的
, ゲノム医科学
, 分子腫瘍学
Research theme for competitive and other funds (18):
- 2024 - 2027 乳癌患者由来オルガノイド・動物モデルの臨床的有用性の検証と新規治療開発への応用
- 2023 - 2026 Mutant p53 - Cancer Immunology Research from the DDX31 axis
- 2022 - 2025 Development of biomarkers and new treatments for metastatic breast cancer by eribulin
- 2020 - 2025 Elucidating mechanisms of therapeutic resistance in breast cancer and the development of innovative therapeutic approach utilizing tumor suppressor activity
- 2017 - 2022 Analysis of sorting zones involved in protein quality control in the endoplasmic reticulum
- 2018 - 2021 Development of integrated treatment for impaired liver regeneration on non-alcoholic steatohepatitis
- 2017 - 2019 Drug discovery in breast cancer utilizing reactivation of tumor suppressors
- 2016 - 2019 Clarification of novel pathophysiological roles of BIG3 in breast cancer cells
- 2016 - 2018 新たなエストロゲン依存性乳癌の多段階発癌機構のシステム的統合理解
- 2014 - 2017 Therapeutic advances in BIG3-PHB2 inhibition targeting the cross-talk between estrogen and growth factors in breast cancer
- 2014 - 2017 Development of multidisciplinary therapy for aged liver insufficiency based on the mechanism of hepatic stellate cell dysfunction.
- 2013 - 2016 Drug development and biological function study of novel estrogen receptor activity modulator BIG3 protein
- 2013 - 2015 内分泌療法耐性乳癌克服に向けた新規エストロゲンシグナル制御のシステム的統合理解
- 2013 - 2015 Identification and characterization of a novel unknown glycosyltransferase GTUF in breast cancer cells
- 2011 - 2014 Development of multidisciplinary therapy based on mechanism of liver insufficiency in a use of Aged partial graft after liver transplantation.
- 2011 - 2013 新規エストロゲン依存性乳癌細胞増殖機構のシステム的統合理解
- 2011 - 2012 Functional roles of a novel glycosyltrasnferase BCGT1 in breast cancer cells
- 2008 - 2009 有効な腫瘍マーカーのない婦人科悪性腫瘍に対する新しい腫瘍マーカーの確立
Show all
Papers (174):
-
Daishiro Kobayashi, Masaya Denda, Junya Hayashi, Kota Hidaka, Yutaka Kohmura, Takaaki Tsunematsu, Kohei Nishino, Harunori Yoshikawa, Kento Ohkawachi, Kiyomi Nigorikawa, et al. Sulfoxide-Mediated Cys-Trp-Selective Bioconjugation that Enables Protein Labeling and Peptide Heterodimerization. ChemistryEurope. 2024. 2. 3-4
-
Jirapat Namkaew, Jun Zhang, Norio Yamakawa, Yoshimasa Hamada, Kazue Tsugawa, Miho Oyadomari, Masato Miyake, Toyomasa Katagiri, Seiichi Oyadomari. Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer. Cancer letters. 2024. 582. 216509-216509
-
Hitomi Sudo, Atsushi B Tsuji, Aya Sugyo, Yosuke Harada, Satoshi Nagayama, Toyomasa Katagiri, Yusuke Nakamura, Tatsuya Higashi. Head-to-head comparison of three chelates reveals DOTAGA promising for 225 Ac labeling of anti-FZD10 antibody OTSA101. Cancer science. 2023. 114. 12. 4677-4690
-
Atsushi Saito, Yasunao Kamikawa, Taichi Ito, Koji Matsuhisa, Masayuki Kaneko, Takumi Okamoto, Tetsuro Yoshimaru, Yosuke Matsushita, Toyomasa Katagiri, Kazunori Imaizumi. p53-independent tumor suppression by cell-cycle arrest via CREB/ATF transcription factor OASIS. Cell reports. 2023. 42. 5. 112479-112479
-
Makoto Takeuchi, Toshihiko Nishisho, Shunichi Toki, Shinji Kawaguchi, Shunsuke Tamaki, Takeshi Oya, Yoshihiro Uto, Toyomasa Katagiri, Koichi Sairyo. Blue light induces apoptosis and autophagy by promoting ROS-mediated mitochondrial dysfunction in synovial sarcoma. Cancer medicine. 2023. 12. 8. 9668-9683
more...
MISC (132):
-
Abdullah S. Ili, Yosuke Matsushita, Yasuko Takahashi, Masato Komatsu, Kazuma Kiyotani, Yasuo Miyoshi, Junko Honda, Shozo Ohsumi, Mitsunori Sasa, Toyomasa Katagiri. Identification and characterization of novel susceptibility genes in hereditary Japanese familial breast cancer. CANCER SCIENCE. 2022. 113. 362-362
-
Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Takeshi Niinuma, Hiromu Suzuki, Tetsuro Yoshimaru, Atsushi Tajima, Issei Imoto, Junko Honda, Yoichi Furukawa, et al. Epigenetic alteration of SALL3 contributes to chemoresistance in triple-negative breast cancer. CANCER SCIENCE. 2022. 113. 752-752
-
大高章, 粟飯原圭祐, 吉丸哲郎, 片桐豊雅. Development of anti-breast cancer peptides using stapling technology. Drug Delivery System. 2020. 35. 3
-
安養寺啓太央, 粟飯原圭佑, 吉丸哲郎, 西川祐輔, 小松正人, 重永章, 片桐豊雅, 大高章. Development of Long-lasting Stapled Peptides Targeting BIG3-PHB2 Interaction in Breast Cancer Cell. 日本薬学会年会要旨集(CD-ROM). 2020. 140th (Web)
-
加藤 廉平, 布川 朋也, 吉丸 哲郎, 松下 洋輔, 尾野 雅哉, 大豆本 圭, 加藤 陽一郎, 片桐 豊雅, 小原 航. 腎癌の癌化過程における新規癌特異分子PRELID2の機能解析. 日本泌尿器科学会総会. 2019. 107回. AOP-090
more...
Lectures and oral presentations (145):
-
筋層浸潤性膀胱癌・多段階進展機構におけるDDX31の重要性
(泌尿器科分子・細胞研究会プログラム・抄録集 2024)
-
乳がん細胞におけるO型糖鎖修飾を介したIRE1の恒常的活性化機構の解明と新規治療戦略の可能性
(日本生化学会大会プログラム・講演要旨集 2023)
-
全ゲノム塩基配列決定により明らかとなった日本人家族性乳癌の新たな潜在的感受性遺伝子(Whole-exome sequencing reveals new potential susceptibility gene for Japanese familial breast cancer)
(日本癌学会総会記事 2023)
-
BIG3-PHB2の相互作用を標的とすることで、HER2陽性乳がんのトラスツズマブ耐性を克服できる(Targeting BIG3-PHB2 interaction overcomes trastuzumab-resistance in patients with HER2-positive breast cancer)
(日本癌学会総会記事 2023)
-
ゴルジ体-小胞体連携による持続的小胞体ストレス応答を通じたがん微小環境制御機構と新規創薬開発(Tumor microenvironmental control via persistent ER stress response by Golgi-ER collaboration and new therapeutics)
(日本癌学会総会記事 2023)
more...
Education (3):
- 1998 - Osaka University Faculty of Medicine
- 1989 - 1991 Kagawa University Graduate School of Agriculture
- 1985 - 1989 Kagawa University Faculty of Agriculture
Professional career (1):
Work history (11):
- 2023/04 - 現在 National Institutes of Biomedical Innovation, Health and Nutrition National Institutes of Biomedical Innovation
- 2023/04 - 2024/03 徳島大学先端酵素学研究所 ゲノム医科学分野 教授
- 2020/04 - 2023/03 Institute of Advanced Medical Sciences
- 2016/04 - 2023/03 徳島大学先端酵素学研究所 ゲノム制御学分野 教授
- 2012/04 - 2016/03 徳島大学疾患プロテオゲノム研究センター ゲノム制御学分野 教授
- 2008/05 - 2012/03 徳島大学疾患ゲノム研究センター ゲノム制御分野 教授
- 2005/05 - 2008/04 東京大学医科学研究所 ヒトゲノム解析センター 准教授
- 2001/01 - 2005/04 東京大学医科学研究所 ヒトゲノム解析センター 助教
- 1998/10 - 2000/12 英国ロンドン大学 ガイズ・セントトーマス校医学部 Research fellow
- 1995/10 - 1998/09 癌研究会癌化学療法センター ゲノム解析研究部
- 1991/04 - 1995/10 Otsuka Pharmaceutical Co.ltd Research fellow
Show all
Return to Previous Page